Novanta Inc (NOVT)

NASD · Technology · Scientific & Technical Instruments · USA

Novanta Inc is a mid cap company (market value between $2 billion and $10 billion) in the Scientific & Technical Instruments industry.

Novanta Inc. supplies core technology solutions to manufacturers of medical devices, life science equipment, and advanced industrial machinery. The company provides components and subsystems for precision medicine, manufacturing, robotics, and surgery through two segments: Automation Enabling Technologies, offering laser steering and robotic motion tools; and Medical Solutions, providing insufflators, pumps, and imaging products.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Novanta Inc stock.

Our verdict on NOVT

Overvalued: intrinsic value $45.78 per share, market price $115.33, margin of safety -151.9% (as of 2026-11-17).

Discounting its cash flows at 12.3% (average of 3 methods) values the shares at $45.78; the price of $115.33 is 152% above that value, and 66% of that value comes from beyond year five.

ETFs with the most weight in NOVT

17 more funds hold it; the full list is part of the paid plan.

More on NOVT

Browse

Peers in Scientific & Technical Instruments

All 32 Scientific & Technical Instruments stocks

Cheaper than NOVT in Scientific & Technical Instruments

9 more in this industry show a wider margin of safety.

Is NOVT undervalued or overvalued?

NOVT is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 12.3% (average of 3 methods) values the shares at $45.78; the price of $115.33 is 152% above that value, and 66% of that value comes from beyond year five.

What is the intrinsic value of NOVT?

$45.78 per share (as of the 2026-11-17 close), against a market price of $115.33. That is a margin of safety of -151.9%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.